Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of the naturally occurring cyclic hydroxamate dealanylalahopcin, which is an inhibitor of procollagen prolyl-4-hydroxylase, were synthesised and shown to be inhibitors of the human hypoxia-inducible factor prolyl hydroxylases.

書誌詳細
主要な著者:	Schlemminger, I, Mole, D, McNeill, L, Dhanda, A, Hewitson, K, Tian, Y, Ratcliffe, P, Pugh, C, Schofield, C
フォーマット:	Journal article
言語:	English
出版事項:	2003

類似資料

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
著者:: Mole, D, 等
出版事項: (2003)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
著者:: McNeill, L, 等
出版事項: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
著者:: Tuckerman, JR, 等
出版事項: (2004)

Regulation of HIF: prolyl hydroxylases.
著者:: Stolze, I, 等
出版事項: (2006)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
著者:: Chan, M, 等
出版事項: (2016)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
著者:: Yeoh, K, 等
出版事項: (2013)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
著者:: Yeh, TL, 等
出版事項: (2017)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
著者:: Tian, Y, 等
出版事項: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
著者:: Chowdhury, R, 等
出版事項: (2016)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
著者:: Mecinović, J, 等
出版事項: (2009)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
著者:: Hewitson, K, 等
出版事項: (2007)

Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.
著者:: Elkins, J, 等
出版事項: (2003)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
著者:: Holt-Martyn, JP, 等
出版事項: (2019)

ENANTIOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
著者:: Baldwin, J, 等
出版事項: (1990)

STEREOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
著者:: Baldwin, J, 等
出版事項: (1990)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
著者:: Cockman, M, 等
出版事項: (2019)

Inhibition of hypoxia inducible factor (HIF) hydroxylases
著者:: Conejo-Garcia, A, 等
出版事項: (2005)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
著者:: Chowdhury, R, 等
出版事項: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
著者:: Rasheduzzaman Chowdhury, 等
出版事項: (2016-08-01)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
著者:: Masson, N, 等
出版事項: (2004)

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
著者:: Hewitson, K, 等
出版事項: (2002)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
著者:: Matthew E Cockman, 等
出版事項: (2019-09-01)

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
著者:: Epstein, A, 等
出版事項: (2001)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
著者:: Willam, C, 等
出版事項: (2006)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
著者:: Masson, N, 等
出版事項: (2003)

Oxygen sensing by HIF hydroxylases.
著者:: Schofield, C, 等
出版事項: (2004)

Signalling hypoxia by HIF hydroxylases.
著者:: Schofield, C, 等
出版事項: (2005)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
著者:: Andrey A. Poloznikov, 等
出版事項: (2021-01-01)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
著者:: Mayer, M, 等
出版事項: (2018)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
著者:: Takahiro Kambara, 等
出版事項: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
著者:: Kiichi Hirota
出版事項: (2021-04-01)

Iron homeostasis and its interaction with prolyl hydroxylases.
著者:: Mole, D
出版事項: (2010)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
著者:: Singh, A, 等
出版事項: (2020)

Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate.
著者:: McNeill, L, 等
出版事項: (2005)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
著者:: Chen, R, 等
出版事項: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
著者:: Chen, R, 等
出版事項: (2014)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
著者:: Flashman, E, 等
出版事項: (2010)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
著者:: Astuti, D, 等
出版事項: (2011)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
著者:: Astuti, D, 等
出版事項: (2010)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
著者:: Moritz J. Strowitzki, 等
出版事項: (2021-04-01)